Action Algernon Pharmaceuticals - AGN

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,095

Prix Achat

0,09

Prix Vente

0,10

Volume échangé

0,00 Fourchette du Jour 0,00

0,06 Plage de 52 semaines 0,14

Clôture Veille

0,095

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

25 954

Volume financier

VWAP

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

VANCOUVER, British Columbia, Feb. 10, 2021 -- InvestorsHub NewsWire -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW...

Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for ...

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN...

Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

Algernon Receives U.S. FDA Clearance for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for...

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory...

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency...

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus VANCOUVER, British Columbia, Canada -- March 6, 2020...

Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) ...

Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) Exhibited Potent...

Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis ...

Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in...

Algernon Pharmaceuticals' NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56%

Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis...

Q&A with Christopher J. Moreau CEO of Algernon Pharmaceuticals

#outlook a {padding:0;} body {width:100%; -webkit-text-size-adjust:100%; -ms-text-size-adjust:100%; margin:0; padding:0;} .ReadMsgBody...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.005	5.55555555556	0.09	0.1	0.09	11680	0.09488014	CS
4	0.005	5.55555555556	0.09	0.1	0.075	35126	0.08357577	CS
12	0.005	5.55555555556	0.09	0.1	0.075	25954	0.08530221	CS
26	0.025	35.7142857143	0.07	0.1225	0.065	27908	0.08643619	CS
52	-0.035	-26.9230769231	0.13	0.14	0.06	27062	0.09075188	CS
156	-1.0525	-91.7211328976	1.1475	1.7375	0.05	21622	0.1660685	CS
260	0.03625	61.7021276596	0.05875	2.975	0.01125	185869	0.07999721	CS

AGN - Frequently Asked Questions (FAQ)

What is the current Algernon Pharmaceuticals share price?

The current share price of Algernon Pharmaceuticals is $ 0,095

What is the 1 year trading range for Algernon Pharmaceuticals share price?

Algernon Pharmaceuticals has traded in the range of $ 0,06 to $ 0,14 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ABJSupreme Metals Corp	$ 0,325 (0,00%)	0
ABCSAbacus Health Products Inc	$ 6,51 (0,00%)	0
ABCAmerican Battery Metals Corporation	$ 0,195 (0,00%)	0
AAWH.UAscend Wellness Holdings Inc	US$ 0,285 (0,00%)	0
AAAlba Minerals Ltd	$ 0,015 (0,00%)	0
ABJSupreme Metals Corp	$ 0,325 (0,00%)	0
ABCSAbacus Health Products Inc	$ 6,51 (0,00%)	0
ABCAmerican Battery Metals Corporation	$ 0,195 (0,00%)	0
AAWH.UAscend Wellness Holdings Inc	US$ 0,285 (0,00%)	0
AAAlba Minerals Ltd	$ 0,015 (0,00%)	0
ABJSupreme Metals Corp	$ 0,325 (0,00%)	0
ABCSAbacus Health Products Inc	$ 6,51 (0,00%)	0
ABCAmerican Battery Metals Corporation	$ 0,195 (0,00%)	0
AAWH.UAscend Wellness Holdings Inc	US$ 0,285 (0,00%)	0
AAAlba Minerals Ltd	$ 0,015 (0,00%)	0

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Algernon Pharmaceuticals Inc (AGN)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

AGN Dernières nouvelles

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for ...

Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) ...

Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis ...

Algernon Pharmaceuticals' NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56%

Q&A with Christopher J. Moreau CEO of Algernon Pharmaceuticals

AGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Algernon Pharmaceuticals Inc (AGN) Cours

Algernon Pharmaceuticals Inc (AGN)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

AGN Dernières nouvelles

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Algernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for ...

Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) ...

Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis ...

Algernon Pharmaceuticals' NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56%

Q&A with Christopher J. Moreau CEO of Algernon Pharmaceuticals

AGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités